One promise of molecular genetics for many of us was that a detailed knowledge of mutant alleles would permit accurate prediction of prognosis and better selection of therapeutic strategies for Mendelian disorders (1) . This presumed predictive promise was naïve and was based on a reductionist view of genotype-phenotype correlations, i.e., that a refined and specific knowledge of a mutation's impact on protein structure and function would permit extrapolation to the phenotype of the intact organism. The reality of molecular genetics, however, is that for many diseases only a subset of mutations reliably predicts phenotype. This lack of genotype-phenotype correlation for many Mendelian disorders shows us that the clinical phenotypes of "simple" Mendelian disorders are complex traits (1, 2) . In retrospect we should have recognized that an individual with a clinical disorder is not the product of the single gene that is disrupted, but that the genetic disruption is embedded within the context of that individual's entire genome and environmental experience. Since genetic backgrounds differ even among first degree relatives, and environmental backgrounds differ even for identical twins, it should be no surprise that phenotypic variability is observed among individuals with identical mutations, including among firstdegree relatives (1) (2) (3) .
We have proposed that the absence of absolute correlation between genotype and phenotype for "single gene" diseases is a consequence of three nondiscrete influences: functional activity thresholds, modifier genes, and systems dynamics (1) . We have examined the first two of these influences previously (1, 2) .
This minireview represents the third part of this trilogy, in which we will consider the dynamics of networked systems. We will go beyond metaboliccontrol analysis, to examine the influences of network structures on their function. Many natural and engineered networks share a structure that leads to an inherent robustness. Analogies with communications networks, such as the Internet, provide insights into why natural, biological networks are robust and tolerate significant variation with a low failure rate. The vulnerabilities that are also structurally inherent in these networks will indicate specific genes and gene products that will be critical to our understanding of disease pathogenesis.
Metabolic Control Analysis and Complex Networks
Historically, biochemical reactions were described as being under control of a single "rate- 1 To whom correspondence should be addressed at Department of Pediatrics, UCLA School of Medicine, Los Angeles, CA 90095-1752. Fax:(310)206-4584. E-mail: emccabe@mednet.ucla.edu. limiting step." According to this traditional model, the kinetics of this rate-limiting step determined the flux through the related pathways. In the 1970s metabolic control analysis (MCA) challenged this concept and focused on the complex and dynamic nature of metabolic control (4) . MCA allowed scientists to look at flux through pathways as determined by the kinetics of the enzymes and transporters, the concentrations of the substrates and metabolites, and the shared control of flux by all constituents in the pathway. MCA could explain some portion of the complexity in the control needed for such metabolic pathways and the fact that control changes under differing physiologic conditions. A more recent application of MCA is the "top-down regulation analysis" which allows one to look at the elasticity of the system or how it adjusts to maintain homeostasis (5) . This approach to regulation analysis, a subset of MCA, reduces the complexity to groups or blocks of reactions that are connected by a few important intermediates (5, 6) .
Top-down regulation analysis approaches complexity in a manner strikingly similar to the model of a scale-free network with blocks of reactions represented by "modules" interacting through a few highly connected critical nodes (see below). Now, with increasing understanding of how metabolic pathways within organisms are complex scale-free networks, we have yet another dimension or framework to explore and explain how a single cell or multicellular organism functions and adapts to the environmental and genetic changes.
Robust Adaptation and Network Connectivity
Normal cellular function requires that the cell's biochemical network be highly interconnected and interactive (7) . A consequence of this connectivity is that alterations in the rates of flux through individual reactions might impact the interconnected networks and the various cellular processes that these networks support. The normal functioning of individual cells, and the multicellular organisms to which individual cells contribute, however, requires stability within the system. Two alternative hypotheses were proposed to explain this stability. One possibility would be that a precise selection of parameters would be required to achieve and maintain stability. Any alterations among individual network parameters would compromise network performance and cellular function. The second hypothesis would be that the robustness of key network properties would permit network dynamics to be determined by system activity within much broader ranges of parameters.
Barkai and Leibler examined a signal transduction model for bacterial chemotaxis by computer simulation (7) . They observed adaptation with maintenance of sensitivity to input signal despite random twofold alterations of all network parameters, or changes by several orders of magnitude for individual parameters. They concluded that robust adaptation was due to network connectivity.
Hartwell, in a companion commentary, suggested that individual networks must be considered in the context of all of the other proteins in the cell and their organization (8) . Not all of a network's parameters will be robust (7) . Therefore, genetic diversity might be due to variations that alter less robust network parameters, and genetic disease may be due to mutant alleles with activities exceeding the limits for robust variation (8) .
Networks as Functional Modules
Hartwell et al. observed that the reductionist approach employed by 20th century biologists was effective in defining the molecular structure and organization of DNA and proteins (9) . They argued that this reductionism was, however, less effective at delineating function, because most biological molecules do not operate independently. They proposed that groups of interacting molecules, including DNA, RNA, proteins, and smaller molecules, are cellular modules that represent discrete functional entities.
Certain properties of biological modules are recognizable by engineers, such as positive and negative feedback loops, and parallel (redundant) circuits (9) . To exploit a modular understanding of cellular function it will be necessary for biologists to understand design principles more familiar to engineers and computer scientists, such as amplifiers, oscillators, and logic circuits. Insight into modular design principles, and development and empiric testing of new models will be required for us to elucidate and manipulate biologically functional modules.
Structures of Complex Networks
Networks built by humans (e.g., economic and communications networks) and those developed by nature (e.g., metabolic and neuronal networks) share certain properties (10, 11) . To be effective, such networks must be able to respond to perturbations and to tolerate disruptions. The structures of networks influence how robustly they will function.
Complex networks may be classified into two fundamental structures (10, 11) (Fig. 1 ). An exponential network exhibits random linkage of nodal pairs until all available links are used (Fig. 1A) (11) . The exponential network is statistically homogeneous: each node has approximately the same number of connections and the probability that nodes will be highly connected declines exponentially. The scalefree network is the second type of structure, and for this network type the probability of node connectivity decreases as a power function, free of scale (Fig.  1B) (11) . A scale-free network is extremely inhomogeneous with a hub-and-spoke structure: most nodes have one or two links, but a few nodes have many links.
A diagrammatic representation of potential e-mail paths through major networks that form the Internet shows us that it is a scale-free network ( Fig. 2A ) (10) . Two protein networks, modeled by Eisenberg et al. based on empirical and predicted functional links, are also shown (12) . These involve the yeast silencing information regulator (SIR) proteins (Fig.  2B ) and the yeast prion protein, Sup35 (Fig. 2C) . Consideration of these biological networks emphasizes the importance of molecular context and interactions to the function of these networks (12). These biological examples appear to be scale-free networks, and to have a hierarchical structure typical of most naturally occurring networks (10) . Within these hierarchical structures, the highly linked nodes have key roles in network behavior.
Error Tolerance and Attack Vulnerability
Complex communication networks and biological systems show a remarkably robust tolerance for random failures of their components (10, 11) . This error tolerance is a fundamental characteristic of the scale-free design. The majority of nodes within the hub-and-spoke structure are located at the outer boundary of overall structure, and their loss does not affect any other nodes. This property, together with the high degree of connectivity within a scale-free network, means that even with as many as 5% of the nodes randomly removed, communication within the system will not be compromised (11) .
The structural properties of scale-free networks that assure their robust performance are also their source of vulnerability: attack on the few highly connected nodes that are critical to network connectivity will threaten network performance (11) . Such disruptions of the most highly interconnected nodes would fragment the network and decrease its ability to survive. Therefore, such a strategic approach, which, for example, might threaten global communication through the Internet, provides a useful model for consideration of genetic disease pathogenesis and therapeutic intervention.
Within the molecular organization and communication of the cell, candidate sites for investigation of disease pathogenesis will be those nodes with high connectivity. These highly connected nodes will include molecular "relay stations," represented by communication "bottlenecks" between modules, and "trunk lines," represented by major pathways between critical nodes. Cellular relay stations would include, for example, a metabolite transporter with high degrees of complexity on either side of the membrane, or a signaling molecule linking multiple input and output modules. Cellular trunk lines would include a critical metabolic pathway, or portion thereof, with limited alternative options or redundant paths through its course, or a transcriptional cascade linking key input variables with output responses.
The analogy with the Internet indicates another possible pathogenic mechanism, and that is the role of traffic volume or flux. For example, large increases in flux through multiple spokes would overload numerous nodes, including the highly connected nodes, thereby reducing the capacity of these key nodes to transfer critical molecular communications and of the cell to respond appropriately. Therefore, genetic disease could result from increases as well as decreases in flux through networks. Mutations blocking key, highly connected nodes could result in buildup behind the block and spill over increasing the flux through other connected modules.
According to the model of the cell and organism as a large scale-free network with a limited number of critical nodes, most mutations will not be lethal, and many may exhibit no clinical phenotype. Disease causing mutations will disrupt molecular communication, fragment the network, and limit the capacity of the cell to respond to change.
Empiric Observations in Complex Systems
Edwards and Palsson studied the robustness of metabolic networks in Escherichia coli by analyzing biochemical, genomic, and strain-specific data (13) . The authors developed in silico models of the metabolic networks and then assessed whether those pathways were robust or sensitive in the face of change. They identified seven reactions that were essential for E. coli to grow on glucose minimal media and grouped these into three categories: pentose phosphate pathway, three-carbon glycolytic enzymes, and tricarboxylic acid cycle. The investigators developed mathematical equations to calculate the sensitivity of cell growth to changes in the levels of the proteins involved in these reactions. They found that within E. coli, the metabolic network was robust. Growth was not compromised until the metabolic flux fell below 15% for transketolase, 19% for the tricarboxylic acid cycle, and 28% for ribose 5-phosphate isomerase. The system showed less robustness for three-carbon glycolysis and growth was compromised at 63 or 110% of optimal activity, possibly because three-carbon glycolysis represents a region with limited alternative paths, or a metabolic trunk line. The authors concluded that integrative bioinformatic analyses, using such factors as metabolic genotype, metabolic phenotype, flux-based analysis, physicochemical constraints, and environmental influences, will be essential in understanding the complex networks involved in biological systems.
Jeong et al. carried out a comparative topological analysis of metabolic networks among 43 organisms in which information was available in a large database containing predictions from genomic annota-tions and empiric data (14) . The authors represented the substrates of metabolic pathways as nodes and the reaction as links. They found that in all 43 organisms, representing archae, bacteria, and eukaryotes, the networks were scale-free networks. In addition, study of the metabolic network of E. coli showed robustness against random errors (such as random DNA mutations). As expected for a scalefree network, disruption of the highly connected nodes or hubs important in overall connectivity resulted in nonfunctional systems. They found that only approximately 4% of substrates observed in any species were common among all of the organisms, and that these substrates were the highly connected nodes. Therefore, despite having significantly different pathways, these very different organisms "had the same topological scaling properties" (14) . The authors speculated that, despite significant individual differences, the overall metabolic network design is identical among organisms, has been shaped by evolutionary pressures to ensure survival of the organisms in the face of genetic and environmental alterations, complies with principles of design for scale-free networks leading to robustness and error tolerance, and may indicate a "common blueprint for the large-scale organization of interactions among all cellular constituents" (14) .
Synergistic Heterozygosity and Proteome Complexity
Understanding the robust nature of scale-free networks and their vulnerabilities will help us to understand the concept of synergistic heterozygosity (15) . Synergistic heterozygosity is terminology developed to explain the observation that a phenotype may be manifested in individuals who are heterozygous for loss-of-function alleles at multiple steps in a metabolic pathway resulting in a clinically significant reduction in pathway function. The robust properties of proteomic networks suggest that not every step will be vulnerable to synergistic heterozygosity. Vulnerability most likely will be observed if each of the two heterozygous steps is a highly connected node, or if the two are in a critical trunk line connecting such nodes.
The proteomic view of genetic disease must consider the complexity of the proteome and its potential genetic modifications. For an enzymatic pathway there is complexity at many levels including enzymes, paralogs, and compartmentalization; alternatively spliced forms; developmental and tissuespecific expression; single nucleotide polymorphisms (SNPs); and the role of various transcription factors.
To evaluate this complexity we must develop and exploit tools to examine genomes, transcriptomes, and proteomes. This approach will require a careful examination and annotation of each node and link in the scale-free systems. Integrative bioinformatic and biomathematical analyses of predicted and empiric information from genomes, transcriptomes, and proteomes will be employed. The volume and layers of data will be incredibly large, and novel and creative approaches will be required to consider and display the complexity of the information. Such analyses undoubtedly will lead to a better understanding of pathogenic mechanisms in genetic disease, including new and evolving concepts such as synergistic heterozygosity.
We have many patients with obvious clinical phenotypes, but no recognizable etiologies. Sequencebased medicine will provide the opportunity to exhaustively examine an individual's genome for simple base changes and DNA rearrangements. However, we must not be seduced by sequencing technology so that we rely solely on this reductionist approach. We must utilize an integrative analysis that considers the detailed genomic and environmental variation within the complexity of the scalefree proteomic network. The power of such a dataintensive integrative approach will be the eventual ability to predict an individual's phenotype far better than we are able today.
Summary and Conclusions
The phenotypes of "simple" Mendelian disorders are complex traits (1-3). As a consequence, for most genetic diseases, we are unable to accurately predict phenotype from genotype for any individual. At this time, we are limited to probabilistic estimates of individual phenotypic features, based on accumulated observations from series of individuals with a specific mutation. Therefore, if our genetic counseling is to be well-informed then it is essential that clinical and genetic data from individuals with specific mutations be accumulated and analyzed.
The absence of absolute genotypic-phenotypic correlations is due to protein activity thresholds, modifier genes, and systems dynamics (1, 2) . In this minireview we have examined systems dynamics with a focus on network complexity and the consequences of that complexity.
As we enter the genomic and proteomic era of medicine, it is essential that we increase our knowledge about the individual components of these networks, the various transcription factors, alternatively spliced and paralogous forms of individual proteins, polymorphisms including SNPs, and environmental influences on functional activity at any node. Improvements in our ability to predict phenotype from genotype, however, will require not only this detailed knowledge but also a thorough understanding of the assembly of these individual components into modules and the interrelatedness of these modules to form functioning, complex systems. The consequences of this assembly will be far greater than the sum of individual components, since, as we have seen, naturally occurring complex networks have structural features that directly influence their dynamic function. These features provide the systems with a robust tolerance to random failure of component parts, and also inform us about specific nodes of vulnerability. Understanding the vulnerabilities will be key to our ability to identify pathogenic mechanisms and intervene effectively to moderate adverse phenotypes.
